EN DE
Watch MeHow Innovative Ltd. A for free: we tell you when fair value or trend changes.
Data-driven stock valuation

MeHow Innovative Ltd. A (301363) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of MeHow Innovative Ltd. A stock ¥4.02, price ¥17.15, that is 76.6% below the price, quality 48 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare CN · ISIN CNE100005WP6

MI MeHow Innovative Ltd. A logo Some data Nov 7, 2026

MeHow Innovative Ltd. A

301363 · SHE
Very expensive, weak quality

Our calculation puts a fair price 77% below what the stock costs today.

Solidly profitable · 17.2% net margin (TTM)
Low debt
Revenue last quarter +19% vs. a year ago.
Quality 48/100
Expensive Growth (revenue 5y +12.9 %/yr in CNY)
0.8% dividend yield · Token dividend
Mixed vs. peers (7/13)
Moderate moat 61/100 · thin data
Some data
Changed on Oct 27: ¥5.93 → ¥4.02
Fair value ¥4.02 · Strongly overvalued
Negative free cash flow
⚠ Dilution
Watch MeHow Innovative Ltd. A for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥30.07 ¥11.09 Fair Value ¥4.02 Oct 2022 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

49‑month range ¥11.09 – ¥30.07 · fair‑value band ¥3.09 – ¥4.27 · the ¥17.15 price screens above the ¥4.02 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow MeHow Innovative Ltd. A in your weekly email

Every Wednesday you see whether MeHow Innovative Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

MeHow Innovative Ltd. designs, develops, manufactures, and sells precision medical device components and products in China and internationally. The company primarily provides home ventilators, precision molds and automation equipment, surgical instruments, etc.

Show moreShow less

It also offers variable dose pen, auto injector, auto secure dose pen; microfluidic solutions and laboratory consumables, such as cuvette, PCR tube, 96-well plates, freezing tubes, culture dish and bottle, suction head, and vacutainer; cardiovascular products, including electrophysiology catheter solutions, ablation catheter, high density mapping catheter, and intracardiac echocardiography; surgical solutions, such as ultrasonic scalpels, staplers, ligating clips, sterile-grade/implant-grade injection components, micro precision equipment components, automated assembly, and others.

In addition, the company offers ophthalmology and ENT consumables, phacoemulsification disposables, IOL delivery systems, and hearing aids and cochlear implants; respiratory testing equipment and consumables, ventilator consumables, pulmonary function testers, and disposable filters; eternal nutrition infusion sets, nasogastric tube and stoma tube, neuromodulation medical devices, and female reproductive health products; baby and maternity products, consumer electronics, drinking water bottles, personal care, etc.

Mehow Innovative Ltd. was founded in 2010 and is headquartered in Shenzhen, China.

Stock analysis

MeHow Innovative Ltd. A (301363) currently trades at ¥17.15, while our model-based Fair Value estimate is ¥4.02, 77% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of ¥8.39 per share, and 1 of the 16 models we run sit above the ¥17.15 price.

Bear case: the Dividend Discount group reads lowest at ¥1.37, and 15 of the 16 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ¥3.09 (bear) to ¥4.27 (bull), the price of ¥17.15 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

MeHow Innovative Ltd. A reported revenue of 1.6B CNY in FY2025 versus 1.1B CNY in FY2021, a compound +9.3%/yr. Reported net income was 283M CNY in FY2025, compounding −2.3%/yr from FY2021.

Key figures

Market cap 14.3B CNY (≈ $2.1B) Mid · P/E ratio 46.4 · P/S ratio 7.62 · EPS (TTM) ¥0.3700 · Dividend yield 0.8% · Net margin 17.2% · Return on equity 8.2% · Return on assets (EBIT) 11.5% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 61 out of 100 (low confidence).

What moves the price

The share trades about 43% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 9% fair-value upside, at −77%, 301363 screens richer than that median.

Fair Value models

Bear ¥3.09 Fair Value ¥4.02 Bull ¥4.27
Price ¥17.15 · Downside -76.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.1953 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income ¥3.63 ¥3.74 ¥4.09 76
ROIC Compounder ¥4.37 ¥4.75 ¥5.29 72
EPV ¥4.37 ¥4.73 ¥5.02 71
All 16 models by family
Earnings-Based
Graham-Dodd ¥2.42 ¥7.80 ¥10.41 64
Lynch FV ¥1.74 ¥2.48 ¥3.22 61
PEG = 1.0 ¥1.74 ¥2.48 ¥3.22 57
EPV ¥4.37 ¥4.73 ¥5.02 71
Dividend Discount
Gordon GGM ¥0.8200 ¥1.46 ¥1.99 68
DDM Multi-Stage ¥0.8200 ¥1.28 ¥1.56 67
Multiples
P/E Multiple ¥5.87 ¥7.82 ¥9.78 63
P/S Multiple ¥4.53 ¥6.05 ¥7.56 58
P/B Multiple ¥15.29 ¥20.39 ¥25.48 55
EV/EBIT ¥7.15 ¥8.96 ¥10.76 66
EV/EBITDA ¥7.59 ¥9.54 ¥11.50 67
EV/Revenue ¥5.59 ¥7.25 ¥8.91 54
Asset-Based
NCAV (Graham) ¥1.62 ¥2.46 ¥3.07 55
Economic Profit
Residual Income ¥3.63 ¥3.74 ¥4.09 76
ROIC Compounder ¥4.37 ¥4.75 ¥5.29 72
Growth Earnings
Growth-Adj P/E ¥4.89 ¥6.98 ¥9.08 67

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 48/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 42
How much profit the company makes from its sales and capital
Quality Growth 23
Are margins and returns getting better?
Cashflow 32
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 42
Does it invest with discipline instead of growing at any price?
Low Volatility 40
How calm the share price moves, does not count
Price momentum 33
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 27
Distance to the 52-week high, does not count
New shares 42
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+2.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.9%
Start year 2020 (pandemic)
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−5.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.8%
Dividend (yield on the price)0.8%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.36% → 21%

301363 screens overvalued: fair value 77% below the price. Compare with Abbott Laboratories, →

Compare MeHow Innovative Ltd. A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 400 stocks

Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 48 · Above median
Fair Value upside −76.6% · Bottom 25%
Profitability
Return on equity (12 months) 8.2% · Above median
Return on assets 6.7% · Top 25%
Net margin (12 months) 17.2% · Top 25%
Operating margin (12 months) 28.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 19.0% · Above median
Dividend yield (12 months) 0.8% · Bottom 25%
Balance sheet
Debt / equity 0.02× · Below median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (12 months) 46.4× · Priciest 25%
P/B 3.66× · Pricier than median
P/S (12 months) 7.62× · Priciest 25%
EV/EBITDA 25.1× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 16
FUTURE (revenue growth)95 · sector 43
PAST (return on equity)33 · sector 0
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)17 · sector 34

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥178.92 ¥202.57 +13% vs 301363
Stryker Corporation SYK $325.73 $358.46 +10% vs 301363
Boston Scientific Corporation BSX $44.02 $48.42 +10% vs 301363
DexCom, Inc DXCM $81.07 $89.18 +10% vs 301363
STERIS plc STE $256.94 $279.53 +9% vs 301363
GE HealthCare Technologies Inc GEHC $84.03 $69.92 −17% vs 301363
Edwards Lifesciences Corporation EW $104.71 $81.94 −22% vs 301363
Abbott Laboratories, ABT $110.51 $75.28 −32% vs 301363
Medtronic plc MDT $102.79 $65.61 −36% vs 301363
Koninklijke Philips N.V PHIA €27.06 €15.23 −44% vs 301363

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

MeHow Innovative Ltd. A: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "MeHow Innovative Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/301363

Frequently asked questions

Is MeHow Innovative Ltd. A (301363) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of ¥4.02 versus a price of ¥17.15, about 77% lower (overvalued).
What is the fair value of 301363?
Our model-based fair value for MeHow Innovative Ltd. A is ¥4.02 (as of Nov 7, 2026), built from audited fundamentals. The current price: ¥17.15.
What is the quality score of 301363?
MeHow Innovative Ltd. A has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MeHow Innovative Ltd. A (301363)?
Our model-based price target is the fair value of ¥4.02 (as of Nov 7, 2026) from 16 valuation models. Cautious scenario ¥3.09, optimistic scenario ¥4.27. It is a calculation from audited fundamentals, not an analyst target.
What is the MeHow Innovative Ltd. A stock forecast for 2026?
Our models put fair value at ¥4.02, about 77% lower versus a price of ¥17.15 (overvalued). Cautious scenario ¥3.09, optimistic scenario ¥4.27. The calculation is refreshed regularly with new filings.
What is the revenue of MeHow Innovative Ltd. A (301363)?
MeHow Innovative Ltd. A reported trailing-twelve-month revenue of about 1.8B CNY (latest available figure, as of Nov 7, 2026).
Does MeHow Innovative Ltd. A pay a dividend?
MeHow Innovative Ltd. A currently shows a dividend yield of 0.83% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of MeHow Innovative Ltd. A (301363) and when is the ex-dividend date?
MeHow Innovative Ltd. A pays a dividend of ¥0.143 per share a year, a dividend yield of 0.8%. The last ex-dividend date was Jun 12, 2026. The payout ratio is 38.6% of earnings. Our assessment: Token dividend. At a yield of 0.8% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.8% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of MeHow Innovative Ltd. A (301363)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MeHow Innovative Ltd. A it is ¥4.02 per share (as of Nov 7, 2026), against a price of ¥17.15. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is MeHow Innovative Ltd. A stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 301363 trades above its calculated fair value: price ¥17.15, fair value ¥4.02, a gap of about −77% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301363?
No. The price is what the market pays today (¥17.15); the fair value is what the company's own numbers justify (¥4.02). For MeHow Innovative Ltd. A the two are ¥13.13 per share apart. That gap is exactly why we show both numbers side by side.
How much is MeHow Innovative Ltd. A worth?
The market values MeHow Innovative Ltd. A at about 14.3B CNY (market capitalisation, as of Nov 7, 2026). Per share that is ¥17.15; our models calculate a fair value of ¥4.02 per share.
What do the bullish and bearish scenarios say about 301363?
Our models span a range for MeHow Innovative Ltd. A: cautious scenario ¥3.09, base ¥4.02, optimistic ¥4.27 per share (as of Nov 7, 2026, price ¥17.15). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301363?
MeHow Innovative Ltd. A trades at a price-to-earnings ratio of 46.4 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥4.02 is built from several models across several years. Other multiples: P/B 3.7, P/S 7.6, EV/EBITDA 25.1.
How solid is the balance sheet of MeHow Innovative Ltd. A (301363)?
Balance-sheet figures for MeHow Innovative Ltd. A (as of Nov 7, 2026): return on equity 8.2%, debt of 0.02 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 301363 from its 52-week high?
MeHow Innovative Ltd. A trades at ¥17.15, about 43% below its 52-week high of ¥30.07 and 20% above the low of ¥14.30 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of ¥4.02 is for.
Which stocks are comparable to MeHow Innovative Ltd. A?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MeHow Innovative Ltd. A stock attractive at the current price?
The data as of Nov 7, 2026: price ¥17.15, calculated fair value ¥4.02 (−77%), Quality Score 48/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301363 calculated?
We run MeHow Innovative Ltd. A through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥4.02 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. MeHow Innovative Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MeHow Innovative Ltd. A (301363)?
The closing price on Nov 10, 2026 was ¥17.15. Our model-based fair value is ¥4.02, about 77% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MeHow Innovative Ltd. A right now?
The price sits above even our optimistic bull case (¥4.27). The favourable scenario is already priced in. Weak quality (48/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of MeHow Innovative Ltd. A

How large is the market capitalisation of MeHow Innovative Ltd. A (301363)?
The market capitalisation of MeHow Innovative Ltd. A is 14.3B CNY (≈ $2.1B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MeHow Innovative Ltd. A (301363)?
The price-to-sales ratio of MeHow Innovative Ltd. A is 7.62 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MeHow Innovative Ltd. A (301363)?
Earnings per share at MeHow Innovative Ltd. A are ¥0.3700 (price ÷ EPS = P/E 46.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MeHow Innovative Ltd. A (301363)?
The dividend yield of MeHow Innovative Ltd. A is 0.8% (payout 38.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MeHow Innovative Ltd. A (301363)?
The net margin of MeHow Innovative Ltd. A is 17.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MeHow Innovative Ltd. A (301363)?
The return on equity (ROE) of MeHow Innovative Ltd. A is 8.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MeHow Innovative Ltd. A (301363)?
On an EBIT basis the return on assets of MeHow Innovative Ltd. A is 11.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MeHow Innovative Ltd. A (301363)?
The operating margin of MeHow Innovative Ltd. A is 28.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MeHow Innovative Ltd. A (301363)?
Revenue at MeHow Innovative Ltd. A is growing +19.0% versus a year earlier (3y avg +4.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MeHow Innovative Ltd. A (301363)?
Earnings per share at MeHow Innovative Ltd. A are growing +3.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does MeHow Innovative Ltd. A (301363) generate?
The free cash flow of MeHow Innovative Ltd. A is −110M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch MeHow Innovative Ltd. A in the live analysis

One click puts MeHow Innovative Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.